
Vildapace M 500mg/50mg Tablet
Marketer
Apace Life Sciences Pvt Ltd
Salt Composition
Metformin (500mg) + Vildagliptin (50mg)
Overview Vildapace M 500mg/50mg Tablet
Diabetic patients with type 2 mellitus may find relief with the dual-action Vildapace M 500mg/50mg Tablet, which effectively manages elevated blood glucose. This dual-therapy approach mitigates the risk of severe diabetic complications, including vision impairment and kidney disease, and potentially lessens the likelihood of cardiovascular events like stroke or heart attack. Vildapace M 500mg/50mg Tablets may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved through consistent medication use, coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, factoring in current health status, blood sugar readings, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels is crucial for preventing future health problems. Adherence to your physician's dietary and exercise plan is paramount. Lifestyle choices significantly impact diabetes management. Commonly reported side effects encompass diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, particularly when combined with insulin or sulfonylureas, is a potential adverse event; understanding its signs and management is crucial. This medication is not universally suitable. Prior to commencing treatment, patients with pre-existing hepatic, renal, or cardiac conditions, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate complete disclosure of all medications to the prescribing physician to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout the course of treatment.
Uses of Vildapace M 500mg/50mg Tablet
Managing type 2 diabetes
Major Benefits of Vildapace M 500mg/50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Vildapace M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Vildapace M 500mg/50mg Tablet:
- Hypoglycemia (low blood glucose level)
- Trembling
- Headache
- Dizziness
- Nausea
- Weakness
- Gastro-esophageal reflux disease
- Increased sweating
- Decreased appetite
How to use Vildapace M 500mg/50mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Vildapace M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Vildapace M 500mg/50mg Tablet works:
One tablet of Vildapace M contains 500mg of one antidiabetic drug and 50mg of a second, offering dual-action glucose control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Vildapace M 500mg/50mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Vildapace M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Vildapace M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Vildapace M 500mg/50mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is recommended.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Vildapace M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Vildapace M 500mg/50mg Tablet :
Should you forget to take a Vildapace M 500mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vildapace M 500mg/50mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
